Larvol Delta - Adverum-Biotechnologies-Announces-Completion-of-Screening-for-Pivotal-Phase-3-ARTEMIS-Trial-of-Ixovec-for-Wet-AgeRelated-Macular-Degeneration

ixoberogene soroparvovec (ADVM-022) - Adverum Biotech

https://www.globenewswire.com/news-release/2025/09/22/3153890/32452/en/Adverum-Biotechnologies-Announces-Completion-of-Screening-for-Pivotal-Phase-3-ARTEMIS-Trial-of-Ixo-vec-for-Wet-Age-Related-Macular-Degeneration.html

Sep 22, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next